awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35606252-F402BC63-850F-46D0-A4EE-4EF7A64E8B07
Q35606252-F402BC63-850F-46D0-A4EE-4EF7A64E8B07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606252-F402BC63-850F-46D0-A4EE-4EF7A64E8B07
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.
P2860
Q35606252-F402BC63-850F-46D0-A4EE-4EF7A64E8B07
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606252-F402BC63-850F-46D0-A4EE-4EF7A64E8B07
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a98e4f9b3a267bd5510db36691c8475cfb7c94c
P2860
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.